Importantly, while PD-L2 expression levels only associate with earlier recurrence and lower age in ChS patients [115], PD-L1 expression has been found to be associated with larger tumor size, advanced tumor grade, earlier recurrence, and shorter OS in ChS patients [116]. The gene discussed is CD274; the disease is neoplasm.